Assessing Health Outcomes for Women with Polycystic Ovary Syndrome and Hypertension

Background: About 6–12% of women in their reproductive years suffer with PCOS, a common endocrine condition characterized through hyperandrogenism, ovulatory dysfunction, as well as polycystic ovarian anatomy. At the same time, hypertension (HTN) is a significant cardiovascular risk factor. Aim: The objective of this study is to evaluate health outcomes associated with young women diagnosed with polycystic ovary syndrome (PCOS) and to determine the relationship between PCOS and hypertension. Methods: Data were collected for 126 patients with polycystic ovary syndrome (PCOS) at different hospitals in Iraq during the follow-up period from March 12, 2023, to April 24, 2024. Blood pressure, metabolic factors, hormonal profiles, and other tests were performed. Fertility outcomes were determined for women. Quality of life was assessed using the SF-36 questionnaire for all patients, some of whom had undergone various treatments. Results: It enrolled clinical outcomes of women with PCOS in this study. Our results showed high in BMI (27.6 ± 12.4), systolic blood pressure (129.7 ± 13.6), and diastolic blood pressure (86.4 ± 8.9). Outcomes of hormonal profiles found Testosterone was 73.5 ± 12.3 (ng/dL), and Estradiol was 126.5 ± 31.6 (pg/mL). Liquid profile characterized in Cholesterol <200mg/dL got 26.98%, elevated LDL got 70.63%, adn decreased HDL got 52.38%. Fertility outcomes found rates of ovarian dysfunction with 75.40% and pregnancy with 31.75%. Quality of life assessment outcomes rised in mental score (64.8 ± 11.4) and physical score (61.5 ± 12.6). Conclusion: According to our study, young women having PCOS had an even greater likelihood of acquiring hypertension. In people with PCOS, the comorbidities of diabetes mellitus and hyperlipidemia may combine and raise the risk in hypertension even more. For young women with PCOS, an early screening for comorbidities and hypertension may be necessary